{"entity":{"type":"insider","cik":"0001365617","url":"/insider/0001365617","json_url":"/insider/0001365617.json","name":"Heron Patrick J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":42,"first":"2015-04-22","last":"2026-01-27","span_basis":"filed_date"},"name_variants":[{"name":"Heron Patrick J","source":"filing","n_filings":42,"first_seen":"2015-04-22","last_seen":"2026-01-27"}],"transactions":[{"id":5909593,"accession":"0001365617-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001365617-26-000002","line_url":"/filing/0001365617-26-000002#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":131425.0,"shares_display":"131,425","price_per_share":68.48,"price_display":"68.48","price_state":"stated","total_value":8999984.0,"total_display":"8,999,984.00","total_whole":"8,999,984","shares_owned_after":459010.0,"shares_owned_after_display":"459,010","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-23","filed_date":"2026-01-27","scope":"insider"},{"id":5072229,"accession":"0001231919-25-000267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-25-000267","line_url":"/filing/0001231919-25-000267#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS X, L.P.; Frazier Life Sciences X, L.P.; Topper James N; FHMLS X, L.L.C.","owner_display_name":"FHMLS X, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":11999988.0,"total_display":"11,999,988.00","total_whole":"11,999,988","shares_owned_after":5219440.0,"shares_owned_after_display":"5,219,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-30","scope":"insider"},{"id":4051172,"accession":"0001415889-25-017576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-017576","line_url":"/filing/0001415889-25-017576#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2646.0,"shares_display":"2,646","price_per_share":13.0803,"price_display":"13.08","price_state":"stated","total_value":34610.4738,"total_display":"34,610.47","total_whole":"34,610","shares_owned_after":27448.0,"shares_owned_after_display":"27,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-17","scope":"insider"},{"id":4558343,"accession":"0001415889-25-015883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-015883","line_url":"/filing/0001415889-25-015883#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":378.0,"shares_display":"378","price_per_share":13.4108,"price_display":"13.41","price_state":"stated","total_value":5069.2824,"total_display":"5,069.28","total_whole":"5,069","shares_owned_after":24802.0,"shares_owned_after_display":"24,802","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-05","filed_date":"2025-06-06","scope":"insider"},{"id":4558340,"accession":"0001415889-25-015883","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015883","line_url":"/filing/0001415889-25-015883#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1890.0,"shares_display":"1,890","price_per_share":13.3214,"price_display":"13.32","price_state":"stated","total_value":25177.446,"total_display":"25,177.45","total_whole":"25,177","shares_owned_after":24424.0,"shares_owned_after_display":"24,424","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-04","filed_date":"2025-06-06","scope":"insider"},{"id":4146578,"accession":"0001415889-25-014415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014415","line_url":"/filing/0001415889-25-014415#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2520.0,"shares_display":"2,520","price_per_share":13.65,"price_display":"13.65","price_state":"stated","total_value":34398.0,"total_display":"34,398.00","total_whole":"34,398","shares_owned_after":22534.0,"shares_owned_after_display":"22,534","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-22","filed_date":"2025-05-23","scope":"insider"},{"id":4146575,"accession":"0001415889-25-014415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-014415","line_url":"/filing/0001415889-25-014415#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2520.0,"shares_display":"2,520","price_per_share":13.66,"price_display":"13.66","price_state":"stated","total_value":34423.2,"total_display":"34,423.20","total_whole":"34,423","shares_owned_after":20014.0,"shares_owned_after_display":"20,014","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-21","filed_date":"2025-05-23","scope":"insider"},{"id":5004538,"accession":"0001415889-25-013620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-013620","line_url":"/filing/0001415889-25-013620#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2520.0,"shares_display":"2,520","price_per_share":13.6178,"price_display":"13.62","price_state":"stated","total_value":34316.856,"total_display":"34,316.86","total_whole":"34,317","shares_owned_after":17494.0,"shares_owned_after_display":"17,494","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4707734,"accession":"0001415889-25-013137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-013137","line_url":"/filing/0001415889-25-013137#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6300.0,"shares_display":"6,300","price_per_share":13.7605,"price_display":"13.76","price_state":"stated","total_value":86691.15,"total_display":"86,691.15","total_whole":"86,691","shares_owned_after":14974.0,"shares_owned_after_display":"14,974","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-15","scope":"insider"},{"id":4707730,"accession":"0001415889-25-013137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-013137","line_url":"/filing/0001415889-25-013137#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2374.0,"shares_display":"2,374","price_per_share":13.7577,"price_display":"13.76","price_state":"stated","total_value":32660.7798,"total_display":"32,660.78","total_whole":"32,661","shares_owned_after":8674.0,"shares_owned_after_display":"8,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-13","filed_date":"2025-05-15","scope":"insider"},{"id":4707706,"accession":"0001415889-25-012768","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-012768","line_url":"/filing/0001415889-25-012768#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6300.0,"shares_display":"6,300","price_per_share":13.6018,"price_display":"13.60","price_state":"stated","total_value":85691.34,"total_display":"85,691.34","total_whole":"85,691","shares_owned_after":6300.0,"shares_owned_after_display":"6,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-09","filed_date":"2025-05-13","scope":"insider"},{"id":4050822,"accession":"0001415889-25-008439","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-008439","line_url":"/filing/0001415889-25-008439#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21.0,"shares_display":"21","price_per_share":43.9338,"price_display":"43.93","price_state":"stated","total_value":922.6098,"total_display":"922.61","total_whole":"923","shares_owned_after":168672.0,"shares_owned_after_display":"168,672","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":4050821,"accession":"0001415889-25-008439","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008439","line_url":"/filing/0001415889-25-008439#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":528.0,"shares_display":"528","price_per_share":44.1125,"price_display":"44.11","price_state":"stated","total_value":23291.4,"total_display":"23,291.40","total_whole":"23,291","shares_owned_after":168651.0,"shares_owned_after_display":"168,651","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-18","scope":"insider"},{"id":4050776,"accession":"0001415889-25-007828","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-007828","line_url":"/filing/0001415889-25-007828#line-3","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":963.0,"shares_display":"963","price_per_share":43.7748,"price_display":"43.77","price_state":"stated","total_value":42155.1324,"total_display":"42,155.13","total_whole":"42,155","shares_owned_after":168123.0,"shares_owned_after_display":"168,123","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-11","filed_date":"2025-03-12","scope":"insider"},{"id":4050774,"accession":"0001415889-25-007828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-007828","line_url":"/filing/0001415889-25-007828","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1335.0,"shares_display":"1,335","price_per_share":42.96838921348315,"price_display":"42.97","price_state":"stated","total_value":57362.7996,"total_display":"57,362.80","total_whole":"57,363","shares_owned_after":166583.0,"shares_owned_after_display":"166,583","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-10","filed_date":"2025-03-12","scope":"insider","n_lines":2},{"id":4951926,"accession":"0001415889-25-007540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-007540","line_url":"/filing/0001415889-25-007540#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":580.0,"shares_display":"580","price_per_share":43.2145,"price_display":"43.21","price_state":"stated","total_value":25064.41,"total_display":"25,064.41","total_whole":"25,064","shares_owned_after":165825.0,"shares_owned_after_display":"165,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-07","filed_date":"2025-03-10","scope":"insider"},{"id":4951922,"accession":"0001415889-25-007540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007540","line_url":"/filing/0001415889-25-007540#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1335.0,"shares_display":"1,335","price_per_share":43.8928,"price_display":"43.89","price_state":"stated","total_value":58596.888,"total_display":"58,596.89","total_whole":"58,597","shares_owned_after":165245.0,"shares_owned_after_display":"165,245","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-10","scope":"insider"},{"id":4769700,"accession":"0001415889-25-007260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-007260","line_url":"/filing/0001415889-25-007260#line-3","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":267.0,"shares_display":"267","price_per_share":44.545,"price_display":"44.54","price_state":"stated","total_value":11893.515,"total_display":"11,893.52","total_whole":"11,894","shares_owned_after":163910.0,"shares_owned_after_display":"163,910","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4769695,"accession":"0001415889-25-007260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-007260","line_url":"/filing/0001415889-25-007260","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1335.0,"shares_display":"1,335","price_per_share":45.565844644194755,"price_display":"45.57","price_state":"stated","total_value":60830.4026,"total_display":"60,830.40","total_whole":"60,830","shares_owned_after":163587.0,"shares_owned_after_display":"163,587","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider","n_lines":2},{"id":3086939,"accession":"0001415889-24-023777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023777","line_url":"/filing/0001415889-24-023777#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":115.0,"shares_display":"115","price_per_share":37.4,"price_display":"37.40","price_state":"stated","total_value":4301.0,"total_display":"4,301.00","total_whole":"4,301","shares_owned_after":162308.0,"shares_owned_after_display":"162,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-20","scope":"insider"},{"id":3152823,"accession":"0000950170-24-107530","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-107530","line_url":"/filing/0000950170-24-107530#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":625000.0,"shares_display":"625,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":4552774.0,"shares_owned_after_display":"4,552,774","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":3054884,"accession":"0001415889-24-023154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-023154","line_url":"/filing/0001415889-24-023154#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230.0,"shares_display":"230","price_per_share":41.5783,"price_display":"41.58","price_state":"stated","total_value":9563.009,"total_display":"9,563.01","total_whole":"9,563","shares_owned_after":162193.0,"shares_owned_after_display":"162,193","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-06","filed_date":"2024-09-10","scope":"insider"},{"id":2278334,"accession":"0001415889-24-010490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-010490","line_url":"/filing/0001415889-24-010490#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"HilleVax, Inc.","issuer_ticker":"HLVX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS X, L.L.C.; Heron Patrick J; FHMLS X, L.P.; Topper James N","owner_display_name":"FHMLS X, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8850.0,"shares_display":"8,850","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":128325.0,"total_display":"128,325.00","total_whole":"128,325","shares_owned_after":8544187.0,"shares_owned_after_display":"8,544,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-08","scope":"insider"},{"id":2898909,"accession":"0001415889-24-007040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-007040","line_url":"/filing/0001415889-24-007040#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21052.0,"shares_display":"21,052","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":199994.0,"total_display":"199,994.00","total_whole":"199,994","shares_owned_after":8785284.0,"shares_owned_after_display":"8,785,284","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-06","scope":"insider"},{"id":8471074,"accession":"0001209191-23-055180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055180","line_url":"/filing/0001209191-23-055180#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2910.0,"shares_display":"2,910","price_per_share":28.3,"price_display":"28.30","price_state":"stated","total_value":82353.0,"total_display":"82,353.00","total_whole":"82,353","shares_owned_after":161963.0,"shares_owned_after_display":"161,963","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-09","filed_date":"2023-11-14","scope":"insider"},{"id":8156001,"accession":"0001209191-23-053662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053662","line_url":"/filing/0001209191-23-053662#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"Frazier Life Sciences VIII, L.P.; Topper James N; FHM LIFE SCIENCES VIII, L.P.; Heron Patrick J; FHM LIFE SCIENCES VIII, L.L.C.","owner_display_name":"Frazier Life Sciences VIII, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80000.0,"shares_display":"80,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":8764232.0,"shares_owned_after_display":"8,764,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-24","filed_date":"2023-10-26","scope":"insider"},{"id":8609045,"accession":"0001209191-23-049614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049614","line_url":"/filing/0001209191-23-049614#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2625.0,"shares_display":"2,625","price_per_share":31.019,"price_display":"31.02","price_state":"stated","total_value":81424.875,"total_display":"81,424.88","total_whole":"81,425","shares_owned_after":159053.0,"shares_owned_after_display":"159,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-15","scope":"insider"},{"id":7871574,"accession":"0001209191-23-049292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-049292","line_url":"/filing/0001209191-23-049292#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3750.0,"shares_display":"3,750","price_per_share":30.6037,"price_display":"30.60","price_state":"stated","total_value":114763.875,"total_display":"114,763.88","total_whole":"114,764","shares_owned_after":156428.0,"shares_owned_after_display":"156,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":7871571,"accession":"0001209191-23-049292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049292","line_url":"/filing/0001209191-23-049292#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4687.0,"shares_display":"4,687","price_per_share":30.3024,"price_display":"30.30","price_state":"stated","total_value":142027.3488,"total_display":"142,027.35","total_whole":"142,027","shares_owned_after":152678.0,"shares_owned_after_display":"152,678","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-13","scope":"insider"},{"id":8680852,"accession":"0001209191-23-048086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048086","line_url":"/filing/0001209191-23-048086#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":147991.0,"shares_display":"147,991","price_per_share":26.25,"price_display":"26.25","price_state":"stated","total_value":3884763.75,"total_display":"3,884,763.75","total_whole":"3,884,764","shares_owned_after":147991.0,"shares_owned_after_display":"147,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-09-05","scope":"insider"},{"id":6612968,"accession":"0001209191-22-045014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-045014","line_url":"/filing/0001209191-22-045014#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"Frazier Life Sciences VIII, L.P.; FHM LIFE SCIENCES VIII, L.L.C.; FHM LIFE SCIENCES VIII, L.P.; Heron Patrick J; Topper James N","owner_display_name":"Frazier Life Sciences VIII, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":8684232.0,"shares_owned_after_display":"8,684,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider"},{"id":6670086,"accession":"0000899243-22-016310","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-016310","line_url":"/filing/0000899243-22-016310#line-2","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"HilleVax, Inc.","issuer_ticker":"HLVX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"Heron Patrick J; FHMLS X, L.P.; Frazier Life Sciences X, L.P.; Topper James N; FHMLS X, L.L.C.","owner_display_name":"Heron Patrick J","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1764706.0,"shares_display":"1,764,706","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":30000002.0,"total_display":"30,000,002.00","total_whole":"30,000,002","shares_owned_after":8535337.0,"shares_owned_after_display":"8,535,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-03","filed_date":"2022-05-03","scope":"insider"},{"id":6918554,"accession":"0001209191-22-009821","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-009821","line_url":"/filing/0001209191-22-009821#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"Topper James N; Frazier Life Sciences VIII, L.P.; Heron Patrick J; FHM LIFE SCIENCES VIII, L.P.; FHM LIFE SCIENCES VIII, L.L.C.","owner_display_name":"Topper James N","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":112665.0,"shares_display":"112,665","price_per_share":7.1006,"price_display":"7.10","price_state":"stated","total_value":799989.099,"total_display":"799,989.10","total_whole":"799,989","shares_owned_after":1484115.0,"shares_owned_after_display":"1,484,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-15","scope":"insider"},{"id":4699498,"accession":"0001567619-21-013730","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001567619-21-013730","line_url":"/filing/0001567619-21-013730","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Imago BioSciences, Inc.","issuer_ticker":"IMGO","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":null,"owner_name":"FHM VII, L.L.C.; Heron Patrick J; FHM VII, L.P.; Frazier Healthcare VII, L.P.; Frazier Healthcare VII-A, L.P.","owner_display_name":"FHM VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":145918.0,"shares_owned_after_display":"145,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-20","scope":"insider","n_lines":2},{"id":2922691,"accession":"0001104659-20-134761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-134761","line_url":"/filing/0001104659-20-134761#line-2","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"Frazier Lifesciences Acquisition Corp","issuer_ticker":"FLAC","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS X, L.L.C.; Frazier Lifesciences Sponsor LLC; Topper James N; Heron Patrick J; Frazier Life Sciences X, L.P.; FHMLS X, L.P.","owner_display_name":"FHMLS X, L.L.C.","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":"Chief Executive Officer","security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":1000000.0,"shares_owned_after_display":"1,000,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-11","scope":"insider"},{"id":3047194,"accession":"0001209191-20-055425","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-055425","line_url":"/filing/0001209191-20-055425#line-3","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"Frazier Life Sciences IX, L.P.; FHMLS IX, L.P.; Topper James N; Heron Patrick J; FHMLS IX, L.L.C.","owner_display_name":"Frazier Life Sciences IX, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":1917157.0,"shares_owned_after_display":"1,917,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-20","filed_date":"2020-10-20","scope":"insider"},{"id":2219568,"accession":"0001209191-20-037076","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-037076","line_url":"/filing/0001209191-20-037076#line-4","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":2309554.0,"shares_owned_after_display":"2,309,554","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-16","scope":"insider"},{"id":2878090,"accession":"0001209191-20-015654","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-015654","line_url":"/filing/0001209191-20-015654#line-4","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550000.0,"shares_display":"550,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":9900000.0,"total_display":"9,900,000.00","total_whole":"9,900,000","shares_owned_after":5009219.0,"shares_owned_after_display":"5,009,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-03","scope":"insider"},{"id":2186360,"accession":"0001209191-20-007104","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-007104","line_url":"/filing/0001209191-20-007104#line-4","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":8500000.0,"total_display":"8,500,000.00","total_whole":"8,500,000","shares_owned_after":10542790.0,"shares_owned_after_display":"10,542,790","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-06","scope":"insider"},{"id":2576701,"accession":"0001209191-20-003162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-003162","line_url":"/filing/0001209191-20-003162#line-1","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"Entasis Therapeutics Holdings Inc.","issuer_ticker":"ETTX","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"Heron Patrick J; Frazier Life Sciences VIII, L.P.; FHM LIFE SCIENCES VIII, L.L.C.; Topper James N; FHM LIFE SCIENCES VIII, L.P.","owner_display_name":"Heron Patrick J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":5.0002,"price_display":"5.00","price_state":"stated","total_value":250010.0,"total_display":"250,010.00","total_whole":"250,010","shares_owned_after":1299953.0,"shares_owned_after_display":"1,299,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-09","filed_date":"2020-01-13","scope":"insider"},{"id":8601348,"accession":"0001209191-19-054525","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-054525","line_url":"/filing/0001209191-19-054525#line-2","is_derivative":false,"issuer_cik":"0001341382","issuer_name":"Phathom Pharmaceuticals, Inc.","issuer_ticker":"PHAT","issuer_name_source":null,"issuer_url":"/issuer/0001341382","owner_cik":null,"owner_name":"FHMLS IX, L.P.; Topper James N; FHMLS IX, L.L.C.; Frazier Life Sciences IX, L.P.; Heron Patrick J","owner_display_name":"FHMLS IX, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1052631.0,"shares_display":"1,052,631","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":19999989.0,"total_display":"19,999,989.00","total_whole":"19,999,989","shares_owned_after":7284269.0,"shares_owned_after_display":"7,284,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-29","filed_date":"2019-10-30","scope":"insider"},{"id":8567999,"accession":"0001209191-19-043022","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-043022","line_url":"/filing/0001209191-19-043022#line-2","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Mirum Pharmaceuticals, Inc.","issuer_ticker":"MIRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":"0001365617","owner_name":"Heron Patrick J","owner_display_name":"Heron Patrick J","owner_url":"/insider/0001365617","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":6750000.0,"total_display":"6,750,000.00","total_whole":"6,750,000","shares_owned_after":3566912.0,"shares_owned_after_display":"3,566,912","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-24","scope":"insider"},{"id":8116928,"accession":"0001209191-19-004783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-004783","line_url":"/filing/0001209191-19-004783#line-1","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"ALPINE IMMUNE SCIENCES, INC.","issuer_ticker":"ALPN","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":null,"owner_name":"FHM LIFE SCIENCES VIII, L.L.C.; FHM LIFE SCIENCES VIII, L.P.; Frazier Life Sciences VIII, L.P.; Heron Patrick J","owner_display_name":"FHM LIFE SCIENCES VIII, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":372439.0,"shares_display":"372,439","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":1999997.43,"total_display":"1,999,997.43","total_whole":"1,999,997","shares_owned_after":2571450.0,"shares_owned_after_display":"2,571,450","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-18","filed_date":"2019-01-22","scope":"insider"},{"id":6047974,"accession":"0001209191-18-053535","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-053535","line_url":"/filing/0001209191-18-053535#line-4","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Entasis Therapeutics Holdings Inc.","issuer_ticker":"ETTX","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":null,"owner_name":"Heron Patrick J; FHM LIFE SCIENCES VIII, L.P.; Frazier Life Sciences VIII, L.P.; FHM LIFE SCIENCES VIII, L.L.C.","owner_display_name":"Heron Patrick J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":375887.0,"shares_display":"375,887","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":5638305.0,"total_display":"5,638,305.00","total_whole":"5,638,305","shares_owned_after":1349953.0,"shares_owned_after_display":"1,349,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-28","filed_date":"2018-10-02","scope":"insider"},{"id":6183637,"accession":"0001104659-18-042315","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-18-042315","line_url":"/filing/0001104659-18-042315#line-4","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Aptinyx Inc.","issuer_ticker":"APTX","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":null,"owner_name":"Frazier Life Sciences VIII, L.P.; FHM LIFE SCIENCES VIII, L.L.C.; Heron Patrick J; FHM LIFE SCIENCES VIII, L.P.","owner_display_name":"Frazier Life Sciences VIII, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":2400000.0,"total_display":"2,400,000.00","total_whole":"2,400,000","shares_owned_after":3190079.0,"shares_owned_after_display":"3,190,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-26","scope":"insider"},{"id":6760270,"accession":"0001209191-18-034197","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-18-034197","line_url":"/filing/0001209191-18-034197","is_derivative":false,"issuer_cik":"0001365617","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001365617","owner_cik":null,"owner_name":"FHM VII, L.L.C.; Frazier Healthcare VII-A, L.P.; Heron Patrick J; FHM VII, L.P.; Frazier Healthcare VII, L.P.","owner_display_name":"FHM VII, L.L.C.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":456099.0,"shares_display":"456,099","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":5929287.0,"total_display":"5,929,287.00","total_whole":"5,929,287","shares_owned_after":1197161.0,"shares_owned_after_display":"1,197,161","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2018-05-30|6760267","ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":36,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001759425","name":"Mirum Pharmaceuticals, Inc.","url":"/issuer/0001759425","role":"Director, Ten percent owner","n_filings":12,"first_seen":"2019-07-24","last_seen":"2026-01-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001776111","name":"MBX Biosciences, Inc.","url":"/issuer/0001776111","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2024-09-17","last_seen":"2025-09-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001787306","name":"Arcutis Biotherapeutics, Inc.","url":"/issuer/0001787306","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2020-02-06","last_seen":"2025-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001888012","name":"HilleVax, Inc.","url":"/issuer/0001888012","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2022-05-03","last_seen":"2024-04-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001626199","name":"ALPINE IMMUNE SCIENCES, INC.","url":"/issuer/0001626199","role":"Ten percent owner","n_filings":2,"first_seen":"2019-01-22","last_seen":"2022-02-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001623715","name":"Imago BioSciences, Inc.","url":"/issuer/0001623715","role":"Director","n_filings":1,"first_seen":"2021-07-20","last_seen":"2021-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001828326","name":"Frazier Lifesciences Acquisition Corp","url":"/issuer/0001828326","role":"Director","n_filings":1,"first_seen":"2020-12-11","last_seen":"2020-12-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001819790","name":"Tarsus Pharmaceuticals, Inc.","url":"/issuer/0001819790","role":"Ten percent owner","n_filings":1,"first_seen":"2020-10-20","last_seen":"2020-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001649094","name":"Vaxcyte, Inc.","url":"/issuer/0001649094","role":"Director","n_filings":1,"first_seen":"2020-06-16","last_seen":"2020-06-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-03-03","last_seen":"2020-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001724344","name":"Entasis Therapeutics Holdings Inc.","url":"/issuer/0001724344","role":"Ten percent owner","n_filings":2,"first_seen":"2018-10-02","last_seen":"2020-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001783183","name":"Phathom Pharmaceuticals, Inc.","url":"/issuer/0001783183","role":"Ten percent owner","n_filings":1,"first_seen":"2019-10-30","last_seen":"2019-10-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001674365","name":"Aptinyx Inc.","url":"/issuer/0001674365","role":"Ten percent owner","n_filings":1,"first_seen":"2018-06-26","last_seen":"2018-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2018-05-30","last_seen":"2018-05-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO INC","url":"/issuer/0001370053","role":"Ten percent owner","n_filings":2,"first_seen":"2017-01-31","last_seen":"2017-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001267565","name":"COLLEGIUM PHARMACEUTICAL, INC","url":"/issuer/0001267565","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2015-05-14","last_seen":"2015-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001610618","name":"Cidara Therapeutics, Inc.","url":"/issuer/0001610618","role":"Director","n_filings":1,"first_seen":"2015-04-22","last_seen":"2015-04-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001365617","retrieved_at":"2026-08-25T02:44:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}